VLN shareholder plans sale of 12,800 ordinary shares on NYSE

A shareholder of VLN filed a notice to sell 12,800 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an approximate aggregate market value of $19,968.00.

Accepted by SEC EDGAR 01/06/2026 - 10:18 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of VLN filed a notice to sell 12,800 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an approximate aggregate market value of $19,968.00. The filing lists total ordinary shares outstanding of 106,342,415 and an approximate sale date of 01/05/2026.

The 12,800 shares to be sold were acquired on 06/01/2017 through an employee stock option plan, with payment described as cash upon exercise dated 01/05/2026. Over the prior three months, the same shareholder reported additional ordinary share sales totaling several transactions, including 24,000 shares for $40,800.00 on 12/05/2025 and 58,900 shares for $90,906.92 on 01/02/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VLN Form 144 filing disclose?

The Form 144 discloses that a shareholder of VLN plans to sell 12,800 ordinary shares on the NYSE through Oppenheimer & Co. Inc., with an approximate aggregate market value of $19,968.00 and an approximate sale date of 01/05/2026.

How many VLN shares does the shareholder plan to sell under this notice?

The shareholder plans to sell 12,800 ordinary shares of VLN, with an indicated aggregate market value of $19,968.00.

How and when were the VLN shares being sold originally acquired?

The 12,800 ordinary shares were acquired on 06/01/2017 through an employee stock option plan, with the filing stating payment as cash upon exercise dated 01/05/2026.

What recent VLN share sales by this person are disclosed in the Form 144?

The notice lists several ordinary share sales in the past three months, including 24,000 shares for $40,800.00 on 12/05/2025, 6,000 shares for $10,200.00 on 12/08/2025, 12,631 shares for $21,760.69 on 12/09/2025, and 58,900 shares for $90,906.92 on 01/02/2026.

How many VLN ordinary shares are reported as outstanding in the filing?

The Form 144 indicates that there are 106,342,415 ordinary shares outstanding.

Which broker is handling the VLN share sale under this Form 144?

The planned sale of 12,800 ordinary shares is listed as being through Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004.

On which exchange are the VLN shares planned to be sold?

The Form 144 states that the 12,800 ordinary shares are to be sold on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965405
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Valens Semiconductor Ltd.
SEC File Number	001-40842
Address of Issuer	8 HANAGAR ST. POB 7152 HOD HASHARON, 4501309 ISRAEL 00000
Phone	972-9-762-6900
Name of Person for Whose Account the Securities are To Be Sold	Jerushalmi Dror
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	12800	19968.00	106342415	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/01/2017	Employee Stock Option Plan	Issuer			12800	01/05/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/05/2025	24000	40800.00
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/08/2025	6000	10200.00
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/09/2025	12631	21760.69
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	01/02/2026	58900	90906.92

144: Remarks and Signature

Remarks
Date of Notice	01/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Dror Jerushalmi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)